Camp4 Therapeutics (CAMP) Asset Utilization Ratio (2024 - 2026)
Camp4 Therapeutics (CAMP) posted Asset Utilization Ratio of 0.04 for Q1 2026, up 2.86% sequentially from 0.03 in Q4 2025, and up 64.63% YoY from 0.02 in Q1 2025.
Analysis
Camp4 Therapeutics (CAMP) Asset Utilization Ratio (2024 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.04 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 64.63% year-over-year to 0.04 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.04 (up 64.63% YoY) and the FY2025 annual result came in at 0.04, up 264.53% from the prior year.
- Asset Utilization Ratio grew to 0.04 in Q1 2026 per CAMP's latest filing, from 0.03 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.06 in Q3 2025 and troughed at 0.01 in Q4 2024.
- A 3-year average of 0.04 and a median of 0.03 in 2025 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio jumped 161.87% in 2025, then surged 64.63% in 2026.
- Over 3 years, Asset Utilization Ratio stood at 0.01 in 2024, then surged by 161.87% to 0.03 in 2025, then climbed by 2.86% to 0.04 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.04, 0.03, and 0.06 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.13 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 10 | Camp4 Therapeutics | 260.10 Mn | 260.10 Mn | - | 0.04 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.04 |
| Mar 31, 2026 | 0.04 |
| Dec 31, 2025 | 0.03 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | 0.05 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.01 |